KOE:174900

AbClon Inc. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:28 UTC

Last close

n/aKRW

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed
    • Computed from the filing for 2025
  • -62.7%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -379.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -305.9%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.12Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed

Five bars, one line

lens 7 of 9
1.46x
1.47x
1.34x
0.67x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.46x

    Its own average over 6 years, 3.22B.

  • Profit1.47x

    Its own average over 6 years, -12.15B.

  • Free cash flow1.34x

    Its own average over 6 years, -10.73B.

  • Debt0.67x

    Its own average over 6 years, 10.50B.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at 1.47 times.

Sales is 1.46 times its own 6-year average; Profit is 1.47 times its own 6-year average; Free cash flow is 1.34 times its own 6-year average; Debt is 0.67 times its own 6-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 6-year average1.46
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Profit against its own 6-year average1.47
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Free cash flow against its own 6-year average1.34
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Debt against its own 6-year average0.67
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    KRW

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.